These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 25837033

  • 1. Linezolid for multidrug-resistant tuberculosis in HIV-infected and -uninfected patients.
    Hughes J, Isaakidis P, Andries A, Mansoor H, Cox V, Meintjes G, Cox H.
    Eur Respir J; 2015 Jul; 46(1):271-4. PubMed ID: 25837033
    [No Abstract] [Full Text] [Related]

  • 2. Linezolid in drug-resistant tuberculosis: haste makes waste.
    Bhuniya S, Mohapatra PR, Panigrahi MK, Behera P, Pradhan G.
    Eur Respir J; 2015 Dec; 46(6):1843-4. PubMed ID: 26621891
    [No Abstract] [Full Text] [Related]

  • 3. Linezolid in drug-resistant tuberculosis: haste makes waste.
    Hughes J, Isaakidis P, Andries A, Mansoor H, Cox V, Meintjes G, Cox H.
    Eur Respir J; 2015 Dec; 46(6):1844-6. PubMed ID: 26621892
    [No Abstract] [Full Text] [Related]

  • 4. Linezolid-containing regimens for the treatment of drug-resistant tuberculosis in South African children.
    Rose PC, Hallbauer UM, Seddon JA, Hesseling AC, Schaaf HS.
    Int J Tuberc Lung Dis; 2012 Dec; 16(12):1588-93. PubMed ID: 23032215
    [Abstract] [Full Text] [Related]

  • 5. Reversal of misfortunes.
    Cohen J.
    Science; 2013 Feb 22; 339(6122):898-903. PubMed ID: 23430629
    [No Abstract] [Full Text] [Related]

  • 6. High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimen.
    Ndjeka N, Schnippel K, Master I, Meintjes G, Maartens G, Romero R, Padanilam X, Enwerem M, Chotoo S, Singh N, Hughes J, Variava E, Ferreira H, Te Riele J, Ismail N, Mohr E, Bantubani N, Conradie F.
    Eur Respir J; 2018 Dec 22; 52(6):. PubMed ID: 30361246
    [Abstract] [Full Text] [Related]

  • 7. Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study.
    Dheda K, Shean K, Zumla A, Badri M, Streicher EM, Page-Shipp L, Willcox P, John MA, Reubenson G, Govindasamy D, Wong M, Padanilam X, Dziwiecki A, van Helden PD, Siwendu S, Jarand J, Menezes CN, Burns A, Victor T, Warren R, Grobusch MP, van der Walt M, Kvasnovsky C.
    Lancet; 2010 May 22; 375(9728):1798-807. PubMed ID: 20488525
    [Abstract] [Full Text] [Related]

  • 8. Drug-resistant tuberculosis. In South Africa, XDR TB and HIV prove a deadly combination.
    Koenig R.
    Science; 2008 Feb 15; 319(5865):894-7. PubMed ID: 18276863
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa.
    Gandhi NR, Moll A, Sturm AW, Pawinski R, Govender T, Lalloo U, Zeller K, Andrews J, Friedland G.
    Lancet; 2006 Nov 04; 368(9547):1575-80. PubMed ID: 17084757
    [Abstract] [Full Text] [Related]

  • 11. Comment on: Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis.
    Sotgiu G, Lange C, Richardson MD, Matteelli A, Centis R, Eker B, Guenther G, Spanevello A, Migliori GB, TBNET.
    J Antimicrob Chemother; 2009 Oct 04; 64(4):879-83; author reply 883-4. PubMed ID: 19651787
    [No Abstract] [Full Text] [Related]

  • 12. Dried blood spots can help decrease the burden on patients dually infected with multidrug-resistant tuberculosis and HIV.
    Zuur MA, Akkerman OW, Touw DJ, van der Werf TS, Cobelens F, Burger DM, Grobusch MP, Alffenaar JW.
    Eur Respir J; 2016 Sep 04; 48(3):932-4. PubMed ID: 27288037
    [No Abstract] [Full Text] [Related]

  • 13. A comparison of linezolid lung tissue concentrations among patients with drug-resistant tuberculosis.
    Kempker RR, Heinrichs MT, Nikolaishvili K, Sabulua I, Bablishvili N, Gogishvili S, Avaliani Z, Little BP, Bernheim A, Derendorf H, Blumberg HM, Vashakidze S, Peloquin CA.
    Eur Respir J; 2018 Feb 04; 51(2):. PubMed ID: 29437945
    [No Abstract] [Full Text] [Related]

  • 14. Review of multidrug-resistant and extensively drug-resistant TB: global perspectives with a focus on sub-Saharan Africa.
    Migliori GB, Dheda K, Centis R, Mwaba P, Bates M, O'Grady J, Hoelscher M, Zumla A.
    Trop Med Int Health; 2010 Sep 04; 15(9):1052-66. PubMed ID: 20545927
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effectiveness and safety of imipenem/clavulanate and linezolid to treat multidrug and extensively drug-resistant tuberculosis at a referral hospital in Brazil.
    Arbex MA, Bonini EH, Kawakame Pirolla G, D'Ambrosio L, Centis R, Migliori GB.
    Rev Port Pneumol (2006); 2016 Sep 04; 22(6):337-341. PubMed ID: 27481315
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Drug-resistant tuberculosis. Research project mimics TB transmission.
    Koenig R.
    Science; 2008 Feb 15; 319(5865):897. PubMed ID: 18276864
    [No Abstract] [Full Text] [Related]

  • 19. [Adverse drug reactions in multidrug-resistant tuberculosis].
    Palmero D, Cruz V, Museli T, Pavlovsky H, Fernández J, Waisman J.
    Medicina (B Aires); 2010 Feb 15; 70(5):427-33. PubMed ID: 20920959
    [Abstract] [Full Text] [Related]

  • 20. Haematological adverse effects associated with linezolid in patients with drug-resistant tuberculosis: an exploratory study.
    Letswee G, Kamau H, Gaida R, Truter I.
    Int J Pharm Pract; 2019 Dec 15; 27(6):575-577. PubMed ID: 31058394
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.